Prof. Hui Wang (Beijing, China)
Prof. Hui Wang is a Professor and Director of the Department of Clinical Laboratory at Peking University People’s Hospital. She is a recipient of the National Science Fund for Distinguished Young Scholars Award, a Newton Advanced Fellow, and recognized as a National Health and Wellness Outstanding Young Expert. Additionally, she serves as the Director of the Department of Laboratory Medicine at Peking University Health Science Center and as the Chairman of the Clinical Microbiology Branch of the China Medical Promotion Association.
Prof. Wang has a long-standing interest in elucidating the molecular epidemiology and drug resistance mechanisms of drug-resistant bacteria, and dynamically tracking the epidemiology, population structure characteristics, and microevolution mechanisms of clinically important drug-resistant bacteria in China. In the past five years, she has published 71 SCI papers as the first or corresponding author in top journals such as Nature Communications, Clinical Infectious Diseases, Genome Medicine, and Drug Resistance Updates. Five of her papers have been selected for the top 1% of ESI highly cited papers.
Prof. Wang has participated in formulating 3 international standards, presided over the formulation of 3 industry standards, and hosted the development of 12 guidelines and consensus documents. She has received awards such as the National Science and Technology Progress Award and the Chinese Medical Science and Technology Progress Award.
Prof. Hui Wang is a Professor and Director of the Department of Clinical Laboratory at Peking University People’s Hospital. She is a recipient of the National Science Fund for Distinguished Young Scholars Award, a Newton Advanced Fellow, and recognized as a National Health and Wellness Outstanding Young Expert. Additionally, she serves as the Director of the Department of Laboratory Medicine at Peking University Health Science Center and as the Chairman of the Clinical Microbiology Branch of the China Medical Promotion Association.
Prof. Wang has a long-standing interest in elucidating the molecular epidemiology and drug resistance mechanisms of drug-resistant bacteria, and dynamically tracking the epidemiology, population structure characteristics, and microevolution mechanisms of clinically important drug-resistant bacteria in China. In the past five years, she has published 71 SCI papers as the first or corresponding author in top journals such as Nature Communications, Clinical Infectious Diseases, Genome Medicine, and Drug Resistance Updates. Five of her papers have been selected for the top 1% of ESI highly cited papers.
Prof. Wang has participated in formulating 3 international standards, presided over the formulation of 3 industry standards, and hosted the development of 12 guidelines and consensus documents. She has received awards such as the National Science and Technology Progress Award and the Chinese Medical Science and Technology Progress Award.